Table 3.
Clinical features | Group 1 | Group 2 |
---|---|---|
Gender (n = 28) | 8 M/6F | 7 M/7F |
Presented with seizures (n = 28) | 12 (n = 14) | 11 (n = 14) |
Age 1st seizure (months) (n = 28) | 30 (5–180) (n = 14) | 87 (23–180) (n = 14) |
Age surgery (months) (n = 28) | 99 (20–192) (n = 14) | 141 (46–188) (n = 14) |
Seizure duration (months) (n = 28) | 67 (5–158) (n = 14) | 55 (1–165) (n = 14) |
Residual post-op tumour (n = 20) | 7 (n = 9) | 6 (n = 11) |
Seizure free at 1 year (n = 23) | 7 (n = 12) | 5 (n = 11) |
Seizure free at last follow-up (n = 23) | 7 (n = 12) | 5 (n = 11) |
For the age data, the values are the mean and range